23andMe Rides Again: FDA Clears Genetic Tests To Predict Disease Risk

23andMe, a genetic testing startup that captured the national imagination a decade ago, appears to have fully emerged from the wilderness. The Food and Drug Administration has cleared the startup to market $199 genetic tests that will tell consumers not whether they have a condition like Parkinson’s or Alzheimer’s, but how likely they might be to […]

Read more "23andMe Rides Again: FDA Clears Genetic Tests To Predict Disease Risk"

History of Next Generation Sequencing

Next generation sequencing (NGS), often referred to as massively parallel sequencing or deep sequencing, refers to a DNA sequencing technology that enables sequencing of millions of small DNA fragments in unison. This generates a massive pool of data and NGS has revolutionized genomic research studies. The data created can reach gigabytes in size (the equivalent […]

Read more "History of Next Generation Sequencing"

Hilary Burton: Get on board with genomics—a call to all clinicians

Personalised medicine has become the “holy grail” of modern medical research and has been embraced by policy makers and healthcare providers as a route to more satisfied patients, more effective and efficient health services, potentially even reducing demand through more effective prediction and prevention of disease. But what do today’s health professionals make of this, […]

Read more "Hilary Burton: Get on board with genomics—a call to all clinicians"